Drug Resistance and Novel Targets for Cancer Therapy: An Overview of Recent Findings-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug Resistance and Novel Targets for Cancer Therapy: An Overview of Recent Findings

Published:2024-04-08 Issue:4 Volume:12 Page:816
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Ouverney Gabriel¹,Hottz Déborah²,Robbs Bruno Kaufmann²^ORCID

Affiliation:

1. Postgraduate Program in Applied Science for Health Products, Faculty of Pharmacy, Fluminense Federal University, Niteroi 24020-141, RJ, Brazil

2. Basic Science Department, Health Institute of Nova Friburgo, Fluminense Federal University, Nova Friburgo 28625-650, RJ, Brazil

Abstract

The complex nature of cancer cells poses a challenge to the scientific community [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2227-9059/12/4/816/pdf

Reference6 articles.

1. Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients;Bray;Sci. Rep.,2019

2. Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib;Naidoo;Cancer,2015

3. Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51;Lee;Breast Cancer Res. BCR,2019

4. Zorzanelli, B.C., Ouverney, G., Pauli, F.P., da Fonseca, A.C.C., de Almeida, E.C.P., de Carvalho, D.G., Possik, P.A., Rabelo, V.W., Abreu, P.A., and Pontes, B. (2022). Pro-Apoptotic Antitumoral Effect of Novel Acridine-Core Naphthoquinone Compounds against Oral Squamous Cell Carcinoma. Molecules, 27.

5. EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors;Ercan;Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into lipid and fatty acid metabolism from Raman spectroscopy;The Analyst;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3